GeoVax Labs, Inc. (GOVX) › Total AssetsGeoVax Labs, Inc. (GOVX) — Total AssetsAnnual figures by period end, from SEC filings.2010-12-31: $2.36M2011-12-31: $1.65M2012-12-31: $1.48M2013-12-31: $2.84M2014-12-31: $1.33M2015-12-31: $1.33M2016-12-31: $610.2K2017-12-31: $490.2K2018-12-31: $642.1K2019-12-31: $468.9K2020-12-31: $10.39M2021-12-31: $11.80M2022-12-31: $31.35M2023-12-31: $9.28M2024-12-31: $8.16M2025-12-31: $6.34M$6.34M2010-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$6.34M-22.2%2026-04-15Balance as of period end2024-12-31$8.16M-12.1%2026-04-15Balance as of period end2023-12-31$9.28M-70.4%2025-03-27Balance as of period end2022-12-31$31.35M+165.7%2024-02-29Balance as of period end2021-12-31$11.80M+13.5%2023-03-23Balance as of period end2020-12-31$10.39M+2116.8%2022-03-09Balance as of period end2019-12-31$468.9K-27.0%2021-03-23Balance as of period end2018-12-31$642.1K+31.0%2020-03-24Balance as of period end2017-12-31$490.2K-19.7%2019-03-26Balance as of period end2016-12-31$610.2K-54.2%2018-03-23Balance as of period end2015-12-31$1.33M-0.1%2017-03-24Balance as of period end2014-12-31$1.33M-53.0%2016-03-16Balance as of period end2013-12-31$2.84M+92.1%2015-03-20Balance as of period end2012-12-31$1.48M-10.2%2014-03-14Balance as of period end2011-12-31$1.65M-30.2%2013-03-18Balance as of period end2010-12-31$2.36M—2012-03-30Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)